The researchers were surprised to learn that childhood cholesterol measurements predicted future artery thickness, as well as those taken later in the adult years.
In the EPIC-Norfolk Perspective Population Study, elevated blood levels of IL-8 in 785 healthy men and women predicted future coronary artery disease events after adjustment for traditional risk factors, C-reactive protein, and white cell count.
In order to evaluate the atheroprotective potential of PON1, we assessed the relationships among PON1-genotype, PON1-activity and risk of future coronary artery disease (CAD), in a large prospective case-control study.
Ultrasound study of CIMT is a reproducible, validated measurement, and increased CIMT and the presence of plaques are predictive of future coronary artery disease and stroke [ 5].
Patients with increased thickness and volume of epicardial adipose tissues have increased severity of coronary atherosclerosis and risk of future coronary artery disease (CAD) [ 13– 17].
5 However, in another prospective population study in apparently healthy volunteers, elevated levels of MIF were associated with an increased risk of future coronary artery disease.
18 Hence, the aims of the present study were (1) to examine if cadmium exposure was associated with future peripheral artery disease measured as ankle-brachial index and (2) if ICAM-1 mediates proatherogenic effects of cadmium exposure.
Cadmium exposure was associated with future peripheral artery disease, supporting the concept that cadmium exposure in the population has proatherogenic effects, although ICAM-1 mediated effects do not seem to be involved.
It has been suggested that cardiac endocrine function is more greatly activated in PAD patients than in non-PAD patients [ 31], which may be why one can predict future coronary artery disease or CVD events in PAD patients with higher BNP levels [ 32].
However, previous observational data examining the precise incremental risk of DM for future adverse coronary artery disease (CAD) events have demonstrated variability, and outcomes-based analyses of DM individuals generally have lacked information regarding CAD prevalence, extent, and severity (2– 5).
